Axa
NUS icon

Axa’s Nu Skin NUS Stock Holding History

Axa’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100,634
Closed -$742K – 1125
2024
Q3 		$742K Hold
100,634
– – ﹤0.01% 914
2024
Q2 		$1.06M Buy
+100,634
New +$1.28M ﹤0.01% 868
2023
Q4 		– Sell
-61,100
Closed -$1.3M – 1113
2023
Q3 		$1.3M Sell
61,100
-1,200
-2% -$31.2K ﹤0.01% 793
2023
Q2 		$2.07M Buy
62,300
+50,300
+419% +$1.85M 0.01% 724
2023
Q1 		$472K Buy
+12,000
New +$499K ﹤0.01% 972
2022
Q4 		– Sell
-77,400
Closed -$2.58M – 1199
2022
Q3 		$2.58M Buy
77,400
+1,100
+1% +$45.8K 0.01% 720
2022
Q2 		$3.3M Sell
76,300
-20,000
-21% -$918K 0.01% 678
2022
Q1 		$4.61M Sell
96,300
-17,400
-15% -$862K 0.01% 660
2021
Q4 		$5.77M Buy
113,700
+68,500
+152% +$3.05M 0.01% 630
2021
Q3 		$1.83M Buy
+45,200
New +$2.29M 0.01% 875
2020
Q3 		– Sell
-164,700
Closed -$6.3M – 1330
2020
Q2 		$6.3M Sell
164,700
-14,300
-8% -$459K 0.02% 546
2020
Q1 		$3.91M Buy
179,000
+25,500
+17% +$767K 0.02% 587
2019
Q4 		$6.29M Buy
153,500
+21,000
+16% +$857K 0.03% 564
2019
Q3 		$5.63M Buy
132,500
+59,300
+81% +$2.49M 0.02% 614
2019
Q2 		$3.61M Buy
+73,200
New +$3.72M 0.01% 737
2015
Q1 		– Sell
-6,100
Closed -$267K – 1472
2014
Q4 		$267K Hold
6,100
– – ﹤0.01% 1229
2014
Q3 		$275K Buy
+6,100
New +$325K ﹤0.01% 1188

Other funds holding NUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Axa's NUS Position: Q4 2024 in Review

Axa sold out of Nu Skin (NUS) in Q4 2024, closing a stake of 100,634 shares — an estimated $742K sold.

Axa first reported a position in NUS in Q3 2014 and held it in 17 quarters. The position peaked at $6.3M in Q2 2020. 200 funds tracked by Wall St. Rank hold NUS as of Q4 2024.

  • Axa reported no remaining Nu Skin position as of Q4 2024 after selling out during the quarter.
  • Axa sold 100,634 Nu Skin shares in Q4 2024, an estimated $742K.
  • Axa first reported a position in Nu Skin in Q3 2014 and held it in 17 quarters.
  • Axa's Nu Skin position peaked at $6.3M in Q2 2020.
  • 200 funds tracked by Wall St. Rank held Nu Skin as of Q4 2024.

Based on Axa's 13F filing for Q4 2024, filed 14 Feb 2025.